Three-Year Progression-Free Survival of Metastatic Breast Cancer Treated With the Palbociclib and Letrozole Combination

被引：0
|
作者：
Karam, Imad [1 ]
Nair, Hari [2 ]
Ghani, Sofia [3 ]
Khalid, Bilal [3 ]
机构：
[1] St Lukes Hosp, PGY II Internal Med, Saginaw, MI USA
[2] St Louis Univ Hosp, PGY V Hematol & Oncol, St Louis, MI 63104 USA
[3] St Louis Univ Hosp, St Louis, MI USA
来源：
AMERICAN JOURNAL OF THERAPEUTICS | 2023年 / 30卷 / 04期
关键词：
D O I：
10.1097/MJT.0000000000001484
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：E408 / E410
页数：3
相关论文
共 50 条
  • [1] Predictors of progression-free survival in patients with metastatic breast cancer receiving palbociclib with letrozole
    Behrouzi, R.
    Moon, S.
    Eaton, D.
    ANNALS OF ONCOLOGY, 2021, 32 : S507 - S507
  • [2] Doubling time of progression-free survival by palbociclib in metastatic breast cancer
    L'Allemain, Gilles
    BULLETIN DU CANCER, 2015, 102 (04) : 300 - 300
  • [3] Improved progression-free survival in metastatic breast cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2018, 19 (02): : E79 - E79
  • [4] Prolonged progression-free survival in metastatic breast cancer
    Mayor, Susan
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (07) : 378 - 378
  • [5] Evaluating the Response of Palbociclib on Progression-Free Survival in Hormone Receptor-Positive Metastatic Breast Cancer
    Shikdar, Sufana
    Hall, Spencer
    Taylor, Brandon
    de los Angeles, Jennifer
    Tahirkheli, Mashal
    Zhao, Daniel
    Razaq, Wajeeha
    ONCOLOGY, 2022, 100 (06) : 337 - 343
  • [6] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M. E.
    Yelle, L.
    Lachaine, J.
    VALUE IN HEALTH, 2012, 15 (07) : A414 - A414
  • [7] PROGRESSION-FREE SURVIVAL AS A SURROGATE FOR OVERALL SURVIVAL IN METASTATIC BREAST CANCER
    Beauchemin, C.
    Cooper, D.
    Lapierre, M.
    Yelle, L.
    Lachaine, J.
    ANNALS OF ONCOLOGY, 2012, 23 : 119 - 120
  • [8] Association between severe neutropenia and progression-free survival in patients with advanced or recurrent breast cancer treated with palbociclib
    Kimura, M.
    Usami, E.
    Yoshimura, T.
    PHARMAZIE, 2020, 75 (12): : 662 - 665
  • [9] Progression-free survival as a potential surrogate for overall survival in metastatic breast cancer
    Beauchemin, Catherine
    Cooper, Dan
    Lapierre, Marie-Eve
    Yelle, Louise
    Lachaine, Jean
    ONCOTARGETS AND THERAPY, 2014, 7 : 1101 - 1110
  • [10] The Impact of Real-World Alternative Dosing Strategies of Palbociclib on Progression-Free Survival in Patients with Metastatic Breast Cancer
    Fu, Fulbert
    Kano, Jessica
    Ma, Julia
    Guindy, Mera
    CURRENT ONCOLOGY, 2022, 29 (03) : 1761 - 1772
12345